Aggregatibacter actinomycetemcomitans, a specific pathogen of localized aggressive periodontitis, produces a cytolethal distending toxin (CDT) that arrests eukaryotic cells irreversibly in G0/G1 or G2/M phase of the cell cycle. Although structural studies show that the aromatic patch region of CdtA plays an important role in its biological activity, the functional sites of CdtA have not been firmly established. In this study, site-specific mutagenesis strategy was employed for cdtA point mutations construction so as to examine the contributions of individual amino acids to receptor binding and the biological activity of holotoxin. The binding ability was reduced in CdtA Y181A BC holotoxin and the biological function of CDT was not weaken in CdtA Y105A BC, CdtA Y125A BC, CdtA F109A BC and CdtA S106N BC holotoxin suggesting that these sites were not critical to CDT. But the binding activity and cell cycle arrest ability of holotoxin complexes were inhibited in CdtA W115G BC. And this site did not affect the holotoxin assembly by size exclusion chromatography. Therefore, W115 might be a critical site of CdtA binding ability. These findings suggest that the functional sites of CdtA are not only in the aromatic patch region. W115, the new functional site is critical for receptor binding and cell cycle arrest, which provides potential targets for pharmacological disruption of CDT activity.
Introduction
Cytolethal distending toxin (CDT) of the oral bacterium Aggregatibacter actinomycetemcomitans (Aa) is a multicomponent bacterial holotoxin that targets most eukaryotic cells to cause distension and cell cycle arrest [1] [2] [3] . Inhibition is relatively rapid, usually occurring within 48-72 h of exposing the cells to holotoxin. It should be noted that the morphologic alterations associated with CDT activity are significantly different from those caused by other known toxins. Protein synthesis is not disrupted and cells cannot divide, which culminates in cell death [4, 5] . CDT is composed of three proteins: CdtA (18-25 kDa), CdtB (30) (31) and CdtC (20) (21) [6] [7] [8] [9] . Therefore, CDT can be viewed as a unique tripartite AB 2 toxin. CdtB is the active (A) subunit, and CdtACdtC are considered as the binding (B 2 ) elements [10, 11] .
Recently, the crystal structure of the Aa CDT began to provide clues for further inquiry into the function of CDT [12] . There is clear evidence that CdtB functions as a type I deoxyribonuclease (DNase I), whereby it activates a DNA-damage-dependent checkpoint that eventually leads cells to apoptosis [13] [14] [15] . Mutations of the DNase I active site residues in CdtB resulted in the loss of nuclease ability and cell cycle arrest in vivo [16, 17] . Although most findings support the conclusion that CdtB is indeed the functional subunit, both CdtA and CdtC are required to achieve maximum cytotoxicity [18, 19] .
The proposed role of CdtA is to adhere to the cell membrane, then to facilitate CdtB entry into cells [20] . A region enriched in the surface-exposed aromatic patch was identified in the H. ducreyi CdtA, which is more than 90% identical to the Aa CDT [11] . Mutagenesis of the putative functional region, which contained the substitutions W91G, W98G, W100G and Y102A, caused holotoxin unable to bind to Hela cells and inactive in cellular assays [21] . Besides, a Cdt groove mutant, CdtA (P103A, Y105A) and CdtC (R43K, Q49A) exhibited diminished binding to cells [22] . In addition, data from immunofluorescence and enzymelinked immunosorbent assays on live cell (CELISA) experiments suggested that purified recombinant CdtA binds to cells in culture [6, 7] .
At present, molecular details of the interactions between CdtA and cell surface receptors are still not clear. More-detailed information is required to determine the role of the putative functional regions in CdtA. We hypothesized that the functional sites of CdtA were not only in the aromatic patch region. To test this hypothesis, we designed a library of site-directed point mutations excluding previously reported mutant sites to identify single amino acid residues which were critical for CdtA activity.
In our study, holotoxin was reconstituted with each mutated cdtA gene product, and its ability of inhibiting cell cycle of Hela cells and promoting CDT cytotoxicity were tested in vitro by flow cytometry and colony-forming units (CFU), respectively. Each mutated cdtA gene product was also tested for its capacity of binding to Chinese hamster ovary (CHO) cells by immunofluorescence. The implications of specific amino acid substitutions on the predicted relationship between structure and function were discussed.
Results
Selection of optimal quality ratio of CdtA, CdtB,CdtC Expression, purification, and characterization of wild-type CDT were similar to previous studies [6, 8, 11, 19] (Table. S1, Figure.S1 ).
To test the biological function of CDT, purified wild-type His 6 -tagged CdtA, CdtB and CdtC were separately added to CHO cell cultures (300 cells per well) in various concentrations (3 -15 mg of protein per reaction) [6, 8, 23, 24] . There was no observed effect on the morphology and proliferation of CHO cells. Similarly, incubated mixtures of CdtA/CdtB (15 mg/3 mg of protein per reaction) and CdtB/CdtC (3 mg/15 mg of protein per reaction) did not affect the growth or survival of CHO cells. Mixtures of all three recombinant proteins in various ratios caused a reduction in the CFU of CHO cell cultures. A combination of 10 mg of His 6 -tagged CdtA, 3 mg of His 6 -tagged CdtB and 10 mg of His 6 -tagged CdtC significantly reduced the survival of 300 cells of CHO cells in culture (Fig.1A) . Furthermore, this combination significantly accumulated Hela cells at G2/M. These results were consistent with the CFU results. CdtA, CdtB or CdtC could not arrest Hela cell cycle at G2/M independently (Fig.1B) . Therefore, in order to achieve consistent and good results, we used this optimal quality ratio in this study.
Selection of cdtA point mutants and isolation of the mutants
Although the surface-exposed aromatic patch (W91G, W98G, W100G and Y102A) [11, 21] are predicted to play an important role in protein function, functional sites of CdtA remains unclear. The aim of the present study was to discover new functional sites of CdtA for the future intervention therapies through specifically inhibiting the toxic effects of CDT. Therefore, we precluded the previously reported mutations [7, 22, [25] [26] [27] , choosing the aromatic CdtA residues W115, Y125 and Y181 for the present experiments. On the basis of a Cdt groove mutant, CdtA (P103A, Y105A), which exhibits a diminished binding to cells [22] , we selected S106N and F109A which are located adjacent to the groove sites to determine whether they were functional sites or not. Y105A was chosen to ensure the effectiveness and consistency of our experiment with previous studies. Site-directed mutagenesis strategy was used to construct a library of mutations (Table.1). Western blot was employed to monitor the expression of the mutant genes, which encoded secreted proteins with mass of approximately 25 kDa ( Figure. S2 ). All the mutant proteins had a calculated pI of 6.72, which was identical to that of wild-type CdtA. The plasmid DNA inserts (669bp) from these transformants were sequenced to confirm the mutations, and no unexpected nucleotide changes were observed (data not shown).
Effect of wild-type and mutant CDTs on Hela cells morphology
A hallmark of CDT action on most eukaryotic cells, including Hela cells, is elongation followed by cellular distension. As expected, cells treated with wild-type holotoxin became elongated followed by significant distension. All of the mutant holotoxins, except CdtA W115G BC, induced significant distension in Hela cells (p,0.001) (Fig. 2A) 
Effect of CdtA mutations on subunits binding
CdtA is characterized of its cell adhesion ability, which facilitates CdtB entry into cells and eventually leads to apoptosis [6, 24] . As shown in Fig. 3A, W115G BC, fluorescence were not located on the cell membrane but were observed in the cytoplasm, which indicated that CdtA subunit were responsible for transferring CDT into cells (Fig.3B) . The fluorescence value of CdtA W115G BC, was significant reduction and even almost invisible compared with wild-type and the other mutant holotoxins (p,0.001).
Effect of CdtA W115G mutation on holotoxin assembly
In this study, we found that W115, the new functional site was critical for receptor binding and cell cycle arrest of CdtA. To test whether mutant CdtA W115G influence holotoxin assembly or not. The ability of wild-type and mutated CdtA W115G subunits to form a stable holotoxin complex were determined by size exclusion chromatography [21] . Both wild-type and mutated CdtA W115G subunits that were refolded into a CDT holotoxin were shifted significantly to a lower molecular weight in gel filtration. Furthermore, all three subunits appear in a stoichiometric ratio in the peak fractions. In the case of the wild-type complex, we observed a second peak eluting near 74 ml. This peak was composed of the three wild-type subunits which could be detected by SDS-PAGE (Figure.S3). It is possible that wild-type holotoxin was assembled successfully even though the absorbance unit (mAU) was extremely low (about 5 mAU) and there was a peak eluting near 45 ml which we considered this was because of CdtB protein oxidation. In addition, we proved that the CdtA W115G BC mutant holotoxin was correctly assembled (Fig.4) . Peak fractions near 7 ml were collected and analyzed by SDS-PAGE, and the CDT subunits were all visualized with Coomassie blue stain.
Discussion
The biological activity of recombinant CDT holotoxin depends on each subunit's recovery of its biological function through denaturation and renaturation in vitro, so as to ensure that CdtA could exert its adhesion function, form a functional holotoxin with CdtB and CdtC on the cell surface and transfer CdtB and CdtC into cells [9, 19, 23, 28, 29] . Now the functional sites of CdtB are detected [2, 8, 10] , but the functional sites of CdtA have not yet been fully proven [22, 25] . The most important ability of CdtA is adhering to cells. Direct evidence of CdtA binding to cells has been obtained from immunofluorescence experiments [6, 7] . A Cdt groove mutant CdtA (P103A, Y105A) exhibit diminished binding to cells [7, 21] . In addition, mutagenesis methods have been employed to provide more detailed information about the functional sites of the proteins [7, 12, 16, 22] . So we introduced cell immunofluorescence in combination with site-directed mutagenesis technology in this study. Aa CDT causes different outcomes of various cell lines depending on the type of the cells. Sensitive cells include HEp-2, Hela, CHO, Vero and Don fibroblasts [30, 31] . In the previous studies, flow cytometry of Hela cells and CFU of CHO cells were utilized to examine the biological function of Aa CDT [7, 8, 22, 23] . This indicates different cells (CHO and Hela) are suited for different biologic activity studies.
Through flow cytometry and CFU, we found that single CdtA, CdtB, CdtC, CdtA/CdtB, CdtB/CdtC or CdtA mutations could not affect the morphology and proliferation of CHO cells or arrest Hela cell cycle. However, mixtures of all three recombinant proteins (wild-type and mutant) in various ratios indeed caused a reduction in CFU of CHO cell cultures and arrested Hela cell cycle at G2/M in varying degree [19] . And we found that 10 mg of His 6 -tagged CdtA: 3 mg of His 6 -tagged CdtB: 10 mg of His 6 -tagged CdtC were the optimal quality ratio in this study.
Dramatic loss of CDT activity was observed when cells were incubated with CdtA W115G BC holotoxins. When this mutant holotoxin was incubated with Hela cells, Hela cell elongation and G2/M cell cycle arrest were not observed, which indicated that CDT holotoxin reconstituted with CdtA W115G was deficient in blocking cell cycle progression [7, 22] . The CFU differences between the W115G mutant and the other five mutants were statistically significant, which indicated that the cytolethal distending function was inhibited in CdtA W115G BC [6, 25] . The weaker fluorescence of CdtA W115G on the cell membrane and the weaker fluorescence CdtA W115G BC holotoxin in cytoplasm compared to the other mutants and wild-type CdtA subunits demonstrated that W115 must be influential in CdtA activity. To test whether mutant CdtA W115G influence holotoxin assembly or not. The ability of wild-type and mutant CdtA W115G subunits to form a stable heterotoxin complex were determined by size exclusion chromatography. The mutant holotoxin of CdtA W115G BC was correctly assembled just like the wild-type CDT. Accordingly, we speculated that the W115 might be a critical site that affects cell adhesion ability, thereby inhibits the cellular entry of CDT holotoxin, which might provide potential targets for pharmacological disruption of CDT activity [22] . CdtA Y181A was also an interesting mutant, which could impair the binding activity and reduced the efficiency of CDT holotoxin into cells though it had little effect on cell cycle arrest. But this effect was not enough to completely block its transport function. Therefore, we hypothesize Y181 is related to adhesion function, but not a critical adhesion site [7] . The other four mutants (CdtA 
Materials and Methods

Bacterial strains, plasmids, cell lines and growth conditions
Aa ATCC 29522, which was used for cloning the cdt genes, was grown on brain-heart infusion agar (Oxiod) at 37uC under a 5% CO 2 -atmosphere. Plasmid pET-15b (Novagen) was used as a template for cloning the wild-type cdt gene and mutagenesis studies [6] . The synthetic oligonucleotide primer pairs shown in Table. S1 were used to amplify the wild-type cdt gene sequences for cloning. All constructs were first transformed into E. coli TOP10 [F -mcrAg(mrr-hsdRMS-mcrBCF80lacZgM15glacX74recA1araD139g (ara-leu)7697galUgalKrpsL(Str r )endA1nupG] chemically competent cells (Invitrogen) for long-term storage and DNA sequencing. Transformants were selected on Luria-Bertani (Oxiod) agar plates containing 50 mg ml 21 ampicillin. DNA sequencing was used to confirm that the fragments were cloned correctly and ligated in the proper orientation. Plasmid DNA was then isolated from each of the clones 
CdtA-Y125A-R 5'-CTAAAGATTGATTAACAAAACGAAAAGCTTCACGGTGTTTACCAGGTTCTATCT-3' pET15b106cdtA S106N CdtA-S106N-F 5'-AACGCAATTGGTTATGGGCTTATCCCAATATATATAATCAGGACTTTGGAAATATTC-3
CdtA-S106N-R 5'-GAATATTTCCAAAGTCCTGATTATATATATTGGGATAAGCCCATAACCAATTGCGTT-3' Hela cells were maintained at 37uC in Dulbecco's modified Eagle medium (DMEM) (Gibco) containing L-glutamine, 10% fetal calf medium (FCS), 100 U/ml penicillin and 100 mg ml 21 streptomycin (Gibco). Chinese hamster ovary (CHO) cells were routinely grown in Ham's F12 (Gibco) medium containing 5% fetal calf serum (Gibco).
Site-directed mutagenesis of cdtA
The mutant residues Y181A, Y125A, W115G, F109A and S106N, which were not involved in previous research, were replaced using site-directed mutagenesis. Synthetic oligonucleotide primer pairs (Table 1) were used to change these codons. Mutant DNA strands were made using Pfu Ultra DNA polymerase (Stratagene) in PCR. The wild-type CdtA plasmid was used as the PCR template for mutagenesis. Nucleotide changes were confirmed by sequencing. Plasmid DNA containing a confirmed sequence was purified with a MiniBEST Plasmid Purification Kit (Takara) and transformed into E. coli BL21 (DE3) competent cells to express the mutated gene.
Isolation of recombinant wild-type CdtA, CdtB, CdtC and mutant CdtA subunit proteins
Isopropyl-b-D-thiogalactoside (IPTG) was used to induce proteins expression [19, 25, 27] . The wild-type and mutants proteins were contained in inclusion bodies, which were isolated, solubilized and refolded using a modification procedure [19, 25] . Briefly, inclusion bodies were isolated by centrifugation (8000 g, 10 min) and washed in binding buffer (pH 7.4). Inclusion bodies were solubilized in binding buffer (pH 7.4) containing 8 M of urea and 100 mM of b-mercaptoethanol. Following centrifugation (12,000 g, 10 min), the supernatants were then passed through a 0.45 micron filter. The solubilized protein was isolated using a 1.0 ml Ni-NTA (nickel-affinity chromatography, Gene Quant) column that had been previously equilibrated with binding buffer (pH 7.4) containing 8 M of urea. The column was first washed with the same buffer and then with washing buffer 1 (20 mM TrisHCl (pH 7.4), 25 mM NaCl, 20 mM imidazole and 8 M urea). Bound protein was eluted with washing buffer 2 (20 mM Tris-HCl (pH 7.4), 25 mM NaCl, 250 mM imidazole and 8 M urea). The isolated protein was then refolded by sequential dialysis in 4, 2, 1, 0.5 and 0 M of urea in PBS (pH 7.4). The last three dialysis buffers contained 15 mM glutathione and 25 mM L-arginine. Ultimately, the refolded subunit was preserved in 10 mM Tris, 75 mM NaCl (pH 7.4) at -70uC. The purified proteins were assessed by SDS-PAGE (SDS-polyacrylamide gel electrophoresis). On average, the yield of recombinant His 6 -tagged proteins was 40-60 mg mL 21 of bacterial culture, as determined by BCA Protein Assay Kit (Novagen).
Western blot analysis
Bacteria collected from IPTG-induced cultures were mixed with 100 ml of gel loading buffer (2% SDS, 0.05 M Tris-HCl (pH 6.8), 10% glycerol, 0.01% b-mercaptoethanol) and heated in a boiling water bath for 5 min. Equal amounts of protein extracts (30 mg/ sample) were separated by 12% SDS-PAGE and blotted onto polyvinyl difluoride membranes (PVDF) (Millipore) at 300 mA for 1 h in a blotting apparatus.protein bands (Bio-Rad). The membrane was blocked with 1% milk in 16TBS buffer (20 mM Tris-HCl (pH 7.4), 0.8% NaCl) for 1 h at room temperature with shaking. The membrane was washed during shaking and then incubated with an anti-His monoclonal antibody (ABcam) at a 1:1000 dilution in 1% milk-TBS at 4uC overnight. The membrane was then incubated with horseradish peroxidase-conjugated antimouse IgG (ABcam) at a 1:2000 dilution. Immunopositive CdtHis 6 protein bands were detected. The experiments were carried out in triplicate.
Cytotoxicity assays
To identify the effects of mutant CDTs on Hela cell morphology, the mutant CdtA-containing holotoxins (10 mg of mutant CdtA: 3 mg of CdtB: 10 mg of CdtC per reaction) were added to Hela cells (1610 6 well
21
). Cell morphologies were compared with that of cultures treated with wild-type holotoxin using light microscopy. Five cells were randomly selected in each group and the average cell area was quantitatively compared among all eight groups.
To quantify the effects of reconstituted mutant holotoxins on CHO proliferation, wild-type and mutant holotoxins (10 mg of wild-type and mutant CdtA: 3 mg of CdtB: 10 mg of CdtC per reaction) were added to the CHO cell cultures for 6 days to allow colonies to form. The medium was then removed, and the cells were fixed with 10% formalin. After incubation for 3-5 min, colonies were stained with crystal violet for 5 min, dried and counted using light microscopy. The number of colonies per well was expressed as CFU. More than a 50 cell mass was recorded as a CFU. These experiments were run in triplicate.
To testify the effects of the heterotoxin made with the mutated CdtA proteins on cell cycle arrest, Hela cells cultures were treated with 10 mg of wild-type and mutant CdtA: 3 mg of CdtB: 10 mg of CdtC per reaction for 48 h. Cells were fixed in ice-cold ethanol (final 70%) and analyzed using FACSCalibur flow cytometry at the University of Nanjing Medical Flow Cytometry facility. These experiments were run in triplicate.
Binding assay
CHO cells, suspended in growth medium, were added to confocal dishes (3000 cells per well) and incubated for 24 h for attachment. The medium was removed, and the cells were washed twice with cold PBS. The purified wild-type and mutant His 6 -tagged proteins individually or in combinations were added to the wells (10 mg of wild-type and mutant CdtA: 3 mg of CdtB: 10 mg of CdtC per reaction, as in the previous experiments). Fresh medium cultures treated with wild-type holotoxin using light microscopy. Five cells were randomly selected in each group and the average cell area was quantitatively compared among all eight groups. was added to the dishes 4 h later, and the plates were fixed in 10% formalin for 15 min at room temperature. Cells were washed three times with PBS at room temperature and incubated with 20 ml of goat serum. The dishes were incubated with 200 ml per well of His-Tag monoclonal antibody diluted 1:500 in 3% BSA-PBS for 30 min at room temperature. Samples were co-stained with DAPI dye to visualized nuclei. Unbound antibody was removed by washing the dishes three times with PBS. One hundred microliter of a 1:180 dilution of 493 nm TRITC-Labeled Goat Anti-Mouse IgG (Beyotime) conjugate in 3% BSA-PBS was then added to each well. The dishes were washed three times, and 10 ml of cold PBS was added per well. These dishes were viewed under an Olympus IX71 fluorescent microscope with a fluorescein isothiocyanate (TRITC)-HYQ filter (excitation wavelength 488-507 nm). Fluorescence values were recorded by a Lecia DM 4000 laser scanning confocal microscope for statistical analyses. Binding experiments were repeated several times to confirm reproducibility.
Holotoxin assembly
To test whether mutant CdtA W115G influence heterotoxin assembly or not. The ability of wild-type and mutated CdtA W115G subunits to form a stable heterotoxin complex were determined by size exclusion chromatography (GE Healthcare). The CDT holotoxin was reconstituted by co-refolding all three subunits together via dialysis at 4uC into a native buffer consisting of 10 mM Tris and 75 mM NaCl (pH 7.4). A total of 1.5 ml protein mixtures were injected onto a HiLoad 16/60 Superdex 200 prep grade column (GE Healthcare) and run at flow rate of 2 ml/min in 10 mM Tris and 75 mM NaCl (pH 7.4) on an AKTA FPLC (GE Healthcare). Fractions of 2 ml were collected.
Statistical methods
One-way ANOVA was used to evaluate the fluorescence values among various mutant CdtA proteins. The CFU results were analyzed by Dunnett's T3 due to the heterogeneity of the variances. All tests used the SPSS 17.0 software. P-values less than 0.05 were considered statistically significant. Figure 4 . Effect of W115G mutation in CdtA on the holotoxin assembly. The ability of mutated CdtA W115G subunit to form a stable heterotoxin complex was determined by size exclusion chromatography. The CDT holotoxin was reconstituted by co-refolding all three subunits together via dialysis at 4uC into a native buffer consisting of 10 mM Tris and 75 mM NaCl (pH 7.4). A total of 1.5 ml protein mixtures were injected onto a HiLoad 16/60 Superdex 200 prep grade column and run at flow rate of 2 ml/min in 10 mM Tris and 75 mM NaCl (pH:7.4) on an AKTA FPLC. Fractions of 2 ml were collected. Peak fractions near 7 ml were collected and analyzed by SDS-PAGE, and the mutant CDT subunits were all visualized with Coomassie blue stain. M. molecular weight markers, A*. CdtA Table S1 Oligonucleotide primers used for wild-type cdtA, cdtB and cdtC cloning. Based on the sequence of the cdt locus of Aa ATCC 29522 (Genbank Accession number AF102554), synthetic oligonucleotide primer pairs were designed to independently amplify the three cdt gene sequences. (DOC)
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